Biogen Pharmachem Ltd is in the business of trading in shares and securities in present and future market.Business Overview: Company used to deal in shares and securities and traded in commodities including agro based and precious metals and other goods in present and future markets
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial ....
BIOGEN PHARMACHEM INDUSTRIES has announced a book closure period scheduled for late September, preceding its Annual General Meeting. This crucial step allows the company to finalize the list of shareholders who are eligible to participate and cast their votes at the upcoming AGM. Shareholders will also have the opportunity to...
Biogen Pharmachem has announced a board meeting on August 5, 2026. The board will consider approving the financial results for the first quarter ended June 30, 2026.
Biogen Pharmachem Industries Limited has confirmed its routine quarterly compliance regarding share dematerialization. For the quarter ended June 30, 2026, the company's Registrar & Share Transfer Agent certified that no physical share certificates were submitted for conversion into electronic (demat) form. This indicates a smooth quarter for share processing, reflecting...
